Journal of the American Heart Association,
Journal Year:
2021,
Volume and Issue:
10(22)
Published: Oct. 30, 2021
Background
Cardiac
surgery-associated
acute
kidney
injury
(CSA-AKI)
is
a
common
postoperative
complication
following
cardiac
surgery.
Currently,
there
are
no
reliable
methods
for
the
early
prediction
of
CSA-AKI
in
hospitalized
patients.
This
study
developed
and
evaluated
diagnostic
use
metabolomics-based
biomarkers
patients
with
CSA-AKI.
Methods
Results
A
total
214
individuals
(122
[AKI],
92
without
AKI
as
controls)
were
enrolled
this
study.
Plasma
samples
analyzed
by
liquid
chromatography
tandem
mass
spectrometry
using
untargeted
targeted
metabolomic
approaches.
Time-dependent
effects
selected
metabolites
investigated
an
swine
model.
Multiple
machine
learning
algorithms
used
to
identify
plasma
positively
associated
Metabolomic
analyses
from
taken
within
24
hours
surgery
useful
distinguishing
controls
AKI.
Gluconic
acid,
fumaric
pseudouridine
significantly
upregulated
random
forest
model
constructed
clinical
parameters
exhibited
excellent
discriminative
ability
(area
under
curve,
0.939;
95%
CI,
0.879-0.998).
In
model,
levels
3
discriminating
increased
time-dependent
manner
(R2,
0.480-0.945).
Use
predictive
was
then
confirmed
validation
cohort
0.972;
0.947-0.996).
The
remained
robust
when
tested
subset
early-stage
0.943;
0.883-1.000).
Conclusions
High-resolution
metabolomics
sufficiently
powerful
developing
novel
biomarkers.
identification
Briefings in Bioinformatics,
Journal Year:
2021,
Volume and Issue:
22(5)
Published: Jan. 12, 2021
Abstract
Interactions
between
proteins
and
small
molecule
metabolites
play
vital
roles
in
regulating
protein
functions
controlling
various
cellular
processes.
The
activities
of
metabolic
enzymes,
transcription
factors,
transporters
membrane
receptors
can
all
be
mediated
through
protein–metabolite
interactions
(PMIs).
Compared
with
the
rich
knowledge
protein–protein
interactions,
little
is
known
about
PMIs.
To
best
our
knowledge,
no
existing
database
has
been
developed
for
collecting
recent
rapid
development
large-scale
mass
spectrometry
analysis
biomolecules
led
to
discovery
large
amounts
Therefore,
we
PMI-DB
provide
a
comprehensive
accurate
resource
A
total
49
785
entries
were
manually
collected
PMI-DB,
corresponding
23
metabolites,
9631
4
species.
Unlike
other
databases
that
only
positive
samples,
provides
non-interaction
which
not
reduces
experimental
cost
biological
experimenters
but
also
facilitates
construction
more
algorithms
researchers
using
machine
learning.
show
convenience
deep
learning-based
method
predict
PMIs
compared
it
several
methods.
results
area
under
curve
precision-recall
are
0.88
0.95,
respectively.
Overall,
user-friendly
interface
browsing
metabolites/proteins
interest,
techniques
identifying
different
species,
important
support
furthering
understanding
freely
accessible
at
http://easybioai.com/PMIDB.
EMBO Reports,
Journal Year:
2023,
Volume and Issue:
24(4)
Published: March 14, 2023
Abstract
Metabolic
processes
play
a
critical
role
in
immune
regulation.
Metabolomics
is
the
systematic
analysis
of
small
molecules
(metabolites)
organisms
or
biological
samples,
providing
an
opportunity
to
comprehensively
study
interactions
between
metabolism
and
immunity
physiology
disease.
Integrating
metabolomics
into
systems
immunology
allows
exploration
multilayered
features
system
molecular
regulatory
mechanism
these
features.
Here,
we
provide
overview
on
recent
technological
developments
metabolomic
applications
immunological
research.
To
begin,
two
widely
used
approaches
are
compared:
targeted
untargeted
metabolomics.
Then,
comprehensive
workflow
computational
tools
available,
including
sample
preparation,
raw
spectra
data
preprocessing,
processing,
statistical
analysis,
interpretation.
Third,
describe
how
integrate
with
other
omics
studies
using
available
tools.
Finally,
discuss
new
its
prospects
for
This
review
provides
guidance
researchers
multiomics
research,
thus
facilitating
application
disease
International Journal of Molecular Sciences,
Journal Year:
2019,
Volume and Issue:
20(23), P. 5831 - 5831
Published: Nov. 20, 2019
Diabetic
nephropathy
(DN)
is
one
of
the
most
perilous
side
effects
diabetes
mellitus
type
1
and
2
(T1DM
T2DM).).
It
known
that
sodium/glucose
cotransporter
inhibitors
(SGLT
2i)
glucagone
like
peptide-1
receptor
agonists
(GLP-1
RAs)
have
renoprotective
effects,
but
molecular
mechanisms
are
still
unknown.
In
clinical
trials
GLP-1
analogs
exerted
important
impact
on
renal
composite
outcomes,
primarily
macroalbuminuria,
possibly
through
suppression
inflammation-related
pathways,
however
enhancement
natriuresis
diuresis
also
possible
nephroprotection.
Dapagliflozin,
canagliflozin,
empagliflozin
SGLT2i
drugs,
useful
in
reducing
hyperglycemia
their
potential
mechanisms,
which
include
blood
pressure
control,
body
weight
loss,
intraglomerular
reduction,
a
decrease
urinary
proximal
tubular
injury
biomarkers.
this
review
we
discussed
synergistic
and/or
additive
GLP
RA
SGLT2
primary
onset
progression
kidney
disease,
implications
current
guidelines
management.
Biomedicines,
Journal Year:
2020,
Volume and Issue:
8(7), P. 222 - 222
Published: July 17, 2020
The
discovery
of
metabolomics-based
biomarkers
has
been
a
focus
recent
kidney
dysfunction
research.
In
the
present
study,
we
aimed
to
identify
metabolites
associated
with
chronic
disease
(CKD)
in
general
population
using
cross-sectional
study
design.
At
baseline,
6.5%
subjects
had
CKD.
Pearson
correlation
analysis
showed
that
28
were
significantly
estimated
glomerular
filtration
rate
(eGFR)
after
Bonferroni
correction.
Among
these
metabolites,
4
acylcarnitines,
12
amino
acids,
biogenic
amines,
1
phosphatidylcholine,
and
sphingolipid
CKD
(
Signal Transduction and Targeted Therapy,
Journal Year:
2023,
Volume and Issue:
8(1)
Published: Jan. 21, 2023
Abstract
Urinary
stone
is
conceptualized
as
a
chronic
metabolic
disorder
punctuated
by
symptomatic
events.
It
has
been
shown
that
the
occurrence
of
calcium
oxalate
monohydrate
(COM)
during
formation
regulated
crystal
growth
modifiers.
Although
crystallization
inhibitors
have
recognized
therapeutic
modality
for
decades,
limited
progress
made
in
discovery
effective
modifiers
to
intervene
with
disease.
In
this
study,
we
used
metabolomics
technologies,
powerful
approach
identify
biomarkers
screening
urine
components
dynamic
progression
bladder
model.
By
in-depth
mining
and
analysis
data,
screened
five
differential
metabolites.
Through
density
functional
theory
studies
bulk
crystallization,
found
three
them
(salicyluric,
gentisic
acid
succinate)
could
effectively
inhibit
nucleation
vitro.
We
thereby
assessed
impact
an
EG-induced
rat
model
kidney
stones.
Notably,
succinate,
key
player
tricarboxylic
cycle,
decrease
deposition
injury
Transcriptomic
further
showed
protective
effect
succinate
was
mainly
through
anti-inflammation,
inhibition
cell
adhesion
osteogenic
differentiation.
These
findings
indicated
may
provide
new
option
urinary
Diagnostics,
Journal Year:
2021,
Volume and Issue:
11(5), P. 864 - 864
Published: May 11, 2021
Chronic
kidney
disease
(CKD)
can
be
treated
if
it
is
detected
early,
but
as
the
progresses,
recovery
becomes
impossible.
Eventually,
renal
replacement
therapy
such
transplantation
or
dialysis
necessary.
Ultrasound
a
test
method
with
which
to
diagnose
cancer,
inflammatory
disease,
nodular
chronic
etc.
It
used
determine
degree
of
inflammation
using
information
size
and
internal
echo
characteristics.
The
progression
in
current
clinical
trial
based
on
value
glomerular
filtration
rate.
However,
changes
even
observed
ultrasound.
In
this
study,
from
total
741
images,
251
normal
328
mild
moderate
CKD
162
severe
images
were
tested.
order
practice,
three
ROIs
set:
cortex
kidney,
boundary
between
medulla,
are
areas
examined
obtain
ultrasound
images.
Parameters
extracted
each
ROI
GLCM
algorithm,
widely
image
analysis.
When
parameter
was
areas,
57
parameters
extracted.
Finally,
58
by
adding
important
for
diagnosis
disease.
artificial
neural
network
(ANN)
composed
input
parameters,
10
hidden
layers,
3
output
layers
(normal,
CKD,
CKD).
Using
ANN
model,
final
classification
rate
95.4%,
epoch
needed
training
38
times,
misclassification
4.6%.